Cognitive Enhancement and Academic Misconduct: A Study Exploring Their Frequency and Relationship

Ethics and Behavior

Volumn 24, Issue 5, 2014, Pages 408-420

  Dubljević, Veljko ^a   Sattler, Sebastian ^b   Racine, Éric ^c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF COLOGNE   (Germany)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

academic misconduct; cheating; cognitive enhancement; moral acceptability; neuroethics

Indexed keywords

EID: 84902845326     PISSN: 10508422     EISSN: None     Source Type: Journal    
DOI: 10.1080/10508422.2013.869747     Document Type: Article

References (60)

1. Appel, J. M. (2008). When the boss turns pusher: A proposal for employee protections in the age of cosmetic neurology. Journal of Medical Ethics, 34, 616-618.
2. Barrett, S. P., Darredeau, C., Bordy, L. E., & Pihl, R. O. (2005). Characteristics of methylphenidate misuse in a university student sample. The Canadian Journal of Psychiatry, 50, 457-461.
3. Beck, L., & Ajzen, I. (1991). Predicting dishonest actions using the theory of planned behavior. Journal of Research in Personality, 25, 285-301.
4. Bostrom, N., & Sandberg, A. (2009). Cognitive enhancement: methods, ethics, regulatory challenges. Science and Engineering Ethics, 15, 311-341.
5. Castaldi, S., Gelatti, U., Orizio, G., Hartung, U., Moreno-Londono, A. M., Nobile, M., & Schulz, P. J. (2012). Use of cognitive enhancement medication among northern Italian university students. Journal of Addiction Medicine, 6, 112-117.
6. Chatterjee, A. (2007). Cosmetic neurology and cosmetic surgery: Parallels, predictions, and challenges. Cambridge Quarterly of Healthcare Ethics, 16, 129-137.
7. Clatworthy, P., Lewis, S., Brichard, L., Hong, Y. T., Izquierdo, D., Clark, L., Robbins, T. W. (2009). Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. The Journal of Neuroscience, 29, 4690-4696.
8. Cochran, J. K., Chamlin, M. B., Wood, P. B., & Sellers, C. S. (1999). Shame, embarrassment, and formal sanction threats: Extending the deterrence/rational choice model to academic dishonesty. Sociological Inquiry, 69, 91-105.
9. Coleman, J. (1990). Foundations of social theory. Cambridge, MA: Harvard University Press.
10. Dietz, P., Striegel, H., Franke, A. G., Lieb, K., Simon, P., & Ulrich, R. (2013). Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy, 33, 44-50.
11. Dubljević, V. (2012a). Principles of justice as the basis for public policy on psycho-pharmacological cognitive enhancement. Law, Innovation and Technology, 4, 67-83.
12. Dubljević, V. (2012b). Toward a legitimate public policy on cognition-enhancement drugs. American Journal of Bioethics-Neuroscience, 3(3), 29-33.
13. Dubljević, V. (2013). Cognitive enhancement, rational choice and justification. Neuroethics, 6, 179-187.
14. Farah, M. J., Illes, J., Cook-Deegan, R., Gardner, H., Kandel, E., King, P., Wolpe, P. R. (2004). Neurocognitive enhancement: What can we do and what should we do? Nature Reviews Neuroscience, 5, 421-425.
15. Forlini, C. & Racine, E. (2009). Autonomy and coercion in academic "cognitive enhancement" using methylphenidate: Perspectives of key stakeholders. Neuroethics, 2, 163-177.
16. Forlini, C., & Racine, E. (2012). Added stakeholders, added value(s) to the cognitive enhancement debate: Are academic discourse and professional policies sidestepping values of stakeholders? AJOB Primary Research, 3, 33-47.
17. Fitz, N. S., & Reiner, P. B. (2013). The challenge of crafting policy for do-it-yourself brain stimulation. Journal of Medical Ethics. Advance online publication. doi:10.1136/medethics-2013-101458
18. Glannon, W. (2008). Psychopharmacological enhancement. Neuroethics, 1, 45-54.
19. Goodman, R. (2010). Cognitive enhancement, cheating, and accomplishment. Kennedy Institute of Ethics Journal, 20, 145-160.
20. Göritz, A. S. (2006). Incentives in web surveys: methodological issues and a review. International Journal of Internet Science, 1, 58-70.
21. Greely, H., Sahakian, B., Harris, J., Kessler, R.C., Gazzaniga, M., Campbell, P., & Farah, M. J. (2008). Towards responsible use of cognitive enhancing drugs by the healthy. Nature, 456, 702-705.
22. Harris, J. (2011). Chemical cognitive enhancement: Is it unfair, unjust, discriminatory, or cheating for healthy adults to use smart drugs. In J. Illes & B. Sahakian (Eds.), The Oxford handbook of neuroethics (pp. 265-272). Oxford, UK: Oxford University Press.
23. Husain, M., & Mehta, M. A. (2011). Cognitive enhancement by drugs in health and disease. Trends in Cognitive Sciences, 15, 28-36.
24. Kerkvliet, J. (1994). Cheating by economics students: A comparison of survey results. Journal of Economic Education, 25, 121-133.
25. Klerman, G. (1972). Psychotropic hedonism vs. pharmacological Calvinism. The Hastings Center Report, 2(4), 1-3.
26. Kroutil, L., Van Brunt, D., Herman-Stahl, M., Heller, D. C., Bray, R. M., & Penne, M. A. (2006). Nonmedical use of prescription stimulants in the United States. Drug and Alcohol Dependence, 84, 135-143.
27. Levy, N. (2007). Neuroethics. Cambridge, UK: Cambridge University Press.
28. Mache, S., Eickenhorst, P., Vitzthum, K., Klapp, B. F., & Groneberg, D. A. (2012). Cognitive-enhancing substance use at German universities: Frequency, reasons and gender differences. Wiener Medizinische Wochenschrift, 162, 262-271.
29. McCabe, D. L., & Trevino, L. K. (1993). Academic dishonesty: Honor codes and other contextual influences. The Journal of Higher Education, 64, 522-538.
30. McCabe, D. L., Trevino, L. K., & Butterfield, K. D. (2001). Cheating in academic institutions: A decade of research. Ethics & Behavior, 11, 219-232.
31. McCabe, D. L., Trevino, L. K., & Butterfield, K. D. (2002). Honor codes and other contextual influences on academic integrity: A replication and extension to modified honor code settings. Research in Higher Education, 43, 357-378.
32. McCabe, S. E., Boyd, C. J., & Teter, C. J. (2009). Subtypes of nonmedical prescription drug misuse. Drug and Alcohol Dependence, 102, 63-70.
33. McCabe, S. E., Knight, J. R., Teter, C. J., & Wechsler, H. (2005). Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction, 100, 96-106.
34. Müller, C. P., & Schumann, G. (2011). To use or not to use: Expanding the view on non-addictive psychoactive drug consumption and its implications. Behavioral and Brain Sciences, 34, 328-347.
35. Novak, P. S., Kroutil, L. A., Williams, R. L., & van Brunt, D. L. (2007). The nonmedical use of prescription ADHD medications: Results from a national Internet panel. Substance Abuse Treatment, Prevention, and Policy, 2, 32.
36. Ong, A. D., & Weiss, D. J. (2000). The impact of anonymity on responses to sensitive questions. Journal of Applied Social Psychology, 30, 1691-1708.
37. Opp, K.-D. (2013). Norms and rationality. Is moral behavior a form of rational action? Theory and Decision, 74, 383-409.
38. Patrzek, J., Sattler, S., van Veen, F., Grunschel, G., & Fries, S. (forthcoming). Investigating the effect of academic procrastination on the frequency and variety of academic misconduct: A panel study. Studies in Higher Education. doi: 10.1080/03075079.2013.854765
39. Porter, S. R. (2004). Raising response rates: what works? New Directions for Institutional Research, 121, 5-21.
40. Posner, R. A., & Rasmusen, E. B. (1999). Creating and enforcing norms, with special reference to sanctions. International Review of Law and Economics, 19, 369-382.
41. President's Council on Bioethics. (2003). Beyond therapy. New York, NY: Dana Press.
42. Racine, E. (2010). Pragmatic neuroethics: Improving treatment and understanding of the mind-brain. Cambridge, MA: MIT Press.
43. Ragan, C. I., Bard, I., & Singh, I. (2012). What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacology, 64, 588-595.
44. Rawls, J. (2001): Justice as fairness: A restatement. Cambridge, MA: Harvard University Press.
45. Rose, S. (2002). 'Smart drugs': Do they work? Are they ethical? Will they be legal? Nature Review Neuroscience, 3, 975-979.
46. Sahakian, B., & Morein-Zamir, S. (2007). Professor's little helper. Nature, 450, 1157-1159.
47. Sattler, S., Forlini, C., Racine, E., & Sauer, C. (2013). Impact of contextual factors and substance characteristics on perspectives toward cognitive enhancement. PLoS ONE, 8, e71452.
48. Sattler, S., Graeff, P., & Willen, S. (2013). Explaining the decision to plagiarize: an empirical test of the interplay between rationality, norms, and opportunity. Deviant Behavior, 34, 444-463.
49. Sattler, S., Sauer, C., Mehlkop, G., & Graeff, P. (2013). The rationale for consuming cognitive enhancement drugs in university students and teachers. PLoS ONE, 8, e68821.
50. Sattler, S., & Wiegel, C. (2013). Test anxiety and cognitive enhancement: The influence of students' worries on their use of performance-enhancing drugs. Substance Use & Misuse, 48, 220-232.
51. Schermer, M. (2008). On the argument that enhancement is "cheating." Journal of Medical Ethics, 34, 85-88.
52. Stafford, J. E. (1966). Influence of preliminary contact on mail returns. Journal of Marketing Research, 3, 410-411.
53. Statistisches Bundesamt. (2012). Bildung und Kultur. Nichtmonetäre hochschulstatistische Kennzahlen-Fachserie 11. [Education and culture: Non-monetary key data on institutions of higher education-Series 11.] Reihe 4.3.1-1980-2010. Statistisches Bundesamt. Retrieved from https://www.destatis.de/DE/Publikationen/Thematisch/BildungForschungKultur/Hochschulen/KennzahlenNichtmonetaer2110431107004.pdf
54. Teixeira, A. A. C., & Rocha, M. F. (2008). Academic cheating in Spain and Portugal: An empirical explanation. International Journal of Iberian Studies, 21, 3-22.
55. Teter, C. J., McCabe, S. E., LaGrange, K., Cranford, J. A., & Boyd, C. J. (2006). Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy, 26, 1501-1510.
56. Tibbetts, S. G., & Myers, D. L. (1999). Low self-control, rational choice, and student test cheating. American Journal of Criminal Justice, 23, 179-200.
57. Tourangeau, R., & Yan, T. (2007). Sensitive questions in surveys. Psychological Bulletin, 133, 859.
58. Tully, T., Bourtchouladze, R., Scott, R., & Tallman, J. (2003). Targeting the cerb pathway for memory enhancers. Nature Reviews Drug Discovery, 2, 267-277.
59. Wechsler, H., Davenport, A., Dowdall, G., Moeykens, B., & Castillo, S. (1994). Health and behavioral consequences of binge drinking in college: A national survey of students at 140 campuses. Journal of the American Medical Association, 272, 1672-1677.
60. Winder-Rhodes, S., Chamberlain, S., Idris, M., Robbins, T. W., Sahakian, B. J., & Müller, U. (2010). Effects of modafinil and parazosin on cognitive and physiological functions in healthy volunteers. Journal of Psychopharmacology, 24, 1649-1657.